99mTc-labeling of Peptidomimetic Antagonist to Selectively Target v&bgr;3 Receptor-Positive Tumor: Comparison of PDA and EDDA as Co-Ligands

By  

Current Radiopharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 1-8

Bentham Science Publishers

Access to resources Recommend Favorite

Biological Evaluation of ^99mTc-HYNIC-EDDA/tricine-(Ser)₃-D4 Peptide for Tumor Targeting

By  

Current Radiopharmaceuticals, Vol. 10, Iss. 2, 2017-08 ,pp. : 123-130

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro and In Vivo Evaluation of [99mTc(CO)3]-Radiolabeled ErbB-2-Targeting Peptides for Breast Carcinoma Imaging

By  

Current Radiopharmaceuticals, Vol. 3, Iss. 4, 2010-10 ,pp. : 308-321

Bentham Science Publishers

Access to resources Recommend Favorite

Radiochemical Evaluation and In Vitro Assessment of the Targeting Ability of a Novel ^99mTc-HYNIC-RGD for U87MG Human Brain Cancer Cells

By  

Current Radiopharmaceuticals, Vol. 10, Iss. 2, 2017-08 ,pp. : 139-144

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro evaluation of ^99mTc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines

By Yurt Lambrecht Fatma   Durkan Kübra   Özgür Aykut   Gündüz Cumhur   Avcı Çığır Biray   Susluer Sunde Yılmaz  

Journal of Drug Targeting, Vol. 21, Iss. 4, 2013-05 ,pp. : 383-388

Informa Healthcare

Access to resources Recommend Favorite